Scroll down to exit.
violator-logo

NOW AVAILABLE!

LUPRON DEPOT-PED 45 MG FOR 6-MONTH ADMINISTRATION1

LUPRON DEPOT-PED is indicated for the treatment of pediatric patients with Central Precocious Puberty (CPP).

In the clinical study for LUPRON DEPOT-PED 45 mg for 6-month administration, the most common (≥4%) adverse reactions were:

  • Injection site reactions
  • Headache
  • Psychiatric events
  • Abdominal pain
  • Diarrhea
  • Hemorrhage
  • Nausea and vomiting
  • Pyrexia
  • Pruritus
  • Pain in extremities
  • Rash
  • Back pain
  • Ligament sprain
  • Increased weight
  • Fracture
  • Breast tenderness
  • Insomnia
  • Chest pain
  • Hyperhidrosis

Please see additional Important Safety Information below.

Please see full Prescribing Information.

violator-rocket-girl

Reference: 1. LUPRON DEPOT-PED [package insert]. North Chicago, IL: AbbVie Inc.

US-LUPR-230014 

You are leaving this website. Links to all outside websites are provided as a convenience to our visitors and do not imply an endorsement or recommendation by AbbVie. AbbVie accepts no responsibility or liability for the content or services of other websites.